{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:57:58Z","timestamp":1792684678642,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The Preserflo-MicroShunt (PF) is an established device for treating glaucoma, effectively reducing intraocular pressure (IOP) with a good safety record. However, its efficacy in eyes with significantly elevated preoperative IOP levels is not well-documented due to exclusion from many clinical studies. This study aims to evaluate PF outcomes in eyes with highly increased IOP and compare them with those having moderately increased levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Retrospectively, eyes diagnosed with primary open angle glaucoma (POAG) or pseudoexfoliation glaucoma (PXG) undergoing PF were analysed. They were categorized into two groups: highly increased IOP (HI-IOP, \u226530\u2009mmHg) and moderately increased IOP (MI-IOP, \u226425\u2009mmHg). IOP, number of IOP lowering medications (NoM), success rates (SR), and postoperative complications were compared at 1, 3, 6, and 12 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>One year postoperatively, IOP was reduced from 39.0\u2009\u00b1\u20097.4\u2009mmHg to 14.4\u2009\u00b1\u20094.4\u2009mmHg in the HI-IOP and from 19.5\u2009\u00b1\u20093.6\u2009mmHg to 14.0\u2009\u00b1\u20094.5\u2009mmHg in the MI-IOP group. NoM decreased significantly in both groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for all). Success rates did not differ between groups during the first year (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05 in all subgroups). However, the HI- IOP group had higher rates of persistent hypotony (7% vs. 0%, <jats:italic>p<\/jats:italic>\u2009=\u20090.02) and tendentially higher rates of choroidal detachment (23% vs. 11%, <jats:italic>p<\/jats:italic>\u2009=\u20090.08). Other adverse events were rare and comparable. Further glaucoma surgery was required in 26% and 19% of cases, respectively (<jats:italic>p<\/jats:italic>\u2009=\u20090.41).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>PF appears to be a suitable option for managing both highly and moderately increased IOP levels in POAG and PXG eyes, with comparable outcomes up to 12 months following surgery.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41433-025-03843-w","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T10:29:16Z","timestamp":1747650556000},"page":"2253-2259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["PRESERFLO\u2122 MicroShunt as a treatment option for highly increased intraocular pressure in primary open angle glaucoma and pseudoexfoliation glaucoma"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0633-6887","authenticated-orcid":false,"given":"Theresa","family":"Theilig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menelaos","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Meller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somar M.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"3843_CR1","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob health. 2017;5:e1221\u2013e1234.","journal-title":"Lancet Glob health"},{"key":"3843_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0002-9394(68)91288-9","volume":"66","author":"JE Cairns","year":"1968","unstructured":"Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol. 1968;66:673\u20139.","journal-title":"Am J Ophthalmol"},{"key":"3843_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jbm.b.33525","volume":"105","author":"L Pinchuk","year":"2017","unstructured":"Pinchuk L, Riss I, Batlle JF, Kato YP, Martin JB, Arrieta E, et al. The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res Part B Appl Biomater. 2017;105:211\u201321.","journal-title":"J Biomed Mater Res Part B Appl Biomater"},{"key":"3843_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/tvst.10.13.26","volume":"10","author":"M Ibarz Barber\u00e1","year":"2021","unstructured":"Ibarz Barber\u00e1 M, Hern\u00e1ndez-Verdejo JL, Bragard J, Burguete J, Fern\u00e1ndez LM, Rivero PT, et al. Evaluation of the ultrastructural and in vitro flow properties of the PRESERFLO MicroShunt. Transl Vis Sci Technol. 2021;10:26.","journal-title":"Transl Vis Sci Technol"},{"key":"3843_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","volume":"5","author":"HJM Beckers","year":"2022","unstructured":"Beckers HJM, Aptel F, Webers CAB, Bluwol E, Mart\u00ednez-de-la-Casa JM, Garc\u00eda-Feijo\u00f3 J, et al. Safety and effectiveness of the PRESERFLO\u00ae MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study. Ophthalmol Glaucoma. 2022;5:195\u2013209.","journal-title":"Ophthalmol Glaucoma"},{"key":"3843_CR6","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.ophtha.2021.05.023","volume":"128","author":"ND Baker","year":"2021","unstructured":"Baker ND, Barnebey HS, Moster MR, Stiles MC, Vold SD, Khatana AK, et al. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, multicenter study. Ophthalmology. 2021;128:1710\u201321.","journal-title":"Ophthalmology"},{"key":"3843_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/IJG.0000000000001734","volume":"30","author":"JF Batlle","year":"2021","unstructured":"Batlle JF, Corona A, Albuquerque R. Long-term results of the PRESERFLO MicroShunt in patients with primary open-angle glaucoma from a single-center nonrandomized study. J Glaucoma. 2021;30:281\u20136.","journal-title":"J Glaucoma"},{"key":"3843_CR8","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1111\/aos.14968","volume":"100","author":"KR Pillunat","year":"2022","unstructured":"Pillunat KR, Herber R, Haase MA, Jamke M, Jasper CS, Pillunat LE. PRESERFLO\u2122 MicroShunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmologica. 2022;100:e779\u2013e790.","journal-title":"Acta Ophthalmologica"},{"key":"3843_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajo.2020.02.020","volume":"215","author":"MB Schlenker","year":"2020","unstructured":"Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS Microshunt with mitomycin C. Am J Ophthalmol. 2020;215:141\u201353.","journal-title":"Am J Ophthalmol"},{"key":"3843_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bjophthalmol-2020-317299","volume":"106","author":"GM Durr","year":"2022","unstructured":"Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma. Br J Ophthalmol. 2022;106:71\u20139.","journal-title":"Br J Ophthalmol"},{"key":"3843_CR11","doi-asserted-by":"crossref","unstructured":"Gardiner BS, Smith DW, Coote M, Crowston JG. Computational modeling of fluid flow and intra-ocular pressure following glaucoma surgery. PloS One. 2010;5:e13178.","DOI":"10.1371\/journal.pone.0013178"},{"key":"3843_CR12","doi-asserted-by":"publisher","first-page":"e0286884","DOI":"10.1371\/journal.pone.0286884","volume":"18","author":"M Ibarz Barber\u00e1","year":"2023","unstructured":"Ibarz Barber\u00e1 M, Hern\u00e1ndez-Verdejo JL, Bragard J, Morales-Fern\u00e1ndez L, Rodr\u00edguez-Carrillo L, Mart\u00ednez Gald\u00f3n F, et al. Bleb geometry and morphology after Preserflo Microshunt surgery: Risk factors for surgical failure. PloS one. 2023;18:e0286884.","journal-title":"PloS one"},{"key":"3843_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ophtha.2023.09.023","volume":"131","author":"JF Panarelli","year":"2024","unstructured":"Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, et al. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: two-year results from a randomized, multicenter study. Ophthalmology. 2024;131:266\u201376.","journal-title":"Ophthalmology"},{"key":"3843_CR14","doi-asserted-by":"publisher","first-page":"e1120","DOI":"10.1111\/aos.15042","volume":"100","author":"FM Wagner","year":"2022","unstructured":"Wagner FM, Schuster AK, Munder A, Muehl M, Chronopoulos P, Pfeiffer N, et al. Comparison of subconjunctival microinvasive glaucoma surgery and trabeculectomy. Acta Ophthalmologica. 2022;100:e1120\u2013e1126.","journal-title":"Acta Ophthalmologica"},{"key":"3843_CR15","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1097\/IJG.0000000000000368","volume":"25","author":"JF Batlle","year":"2016","unstructured":"Batlle JF, Fantes F, Riss I, Pinchuk L, Alburquerque R, Kato YP, et al. Three-year follow-up of a novel aqueous humor MicroShunt. J Glaucoma. 2016;25:e58\u201365.","journal-title":"J Glaucoma"},{"key":"3843_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95217-x","volume":"11","author":"JM Mart\u00ednez-de-la-Casa","year":"2021","unstructured":"Mart\u00ednez-de-la-Casa JM, Saenz-Franc\u00e9s F, Morales-Fernandez L, Perucho L, Mendez C, Fernandez-Vidal A, et al. Clinical outcomes of combined Preserflo Microshunt implantation and cataract surgery in open-angle glaucoma patients. Sci Rep. 2021;11:15600.","journal-title":"Sci Rep"},{"key":"3843_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jfo.2015.05.005","volume":"38","author":"I Riss","year":"2015","unstructured":"Riss I, Batlle J, Pinchuk L, Kato YP, Weber BA, Parel J-M. R\u00e9sultats \u00e0 un an de l\u2019efficacit\u00e9 et de l\u2019innocuit\u00e9 du MicroShunt InnFocus selon l\u2019emplacement et la concentration de MMC. J Francais d\u2019ophtalmologie. 2015;38:855\u201360.","journal-title":"J Francais d\u2019ophtalmologie"},{"key":"3843_CR18","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ophtha.2022.07.003","volume":"129","author":"SJ Gedde","year":"2022","unstructured":"Gedde SJ, Feuer WJ, Lim KS, Barton K, Goyal S, Ahmed II, et al. Treatment outcomes in the primary tube versus trabeculectomy study after 5 years of follow-up. Ophthalmology. 2022;129:1344\u201356.","journal-title":"Ophthalmology"},{"key":"3843_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ajo.2022.02.027","volume":"240","author":"EC Bowden","year":"2022","unstructured":"Bowden EC, Choudhury A, Gedde SJ, Feuer WJ, Christakis PG, Savatovsky E, et al. Risk factors for failure of tube shunt surgery: a pooled data analysis. Am J Ophthalmol. 2022;240:217\u201324.","journal-title":"Am J Ophthalmol"},{"key":"3843_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ogla.2024.06.001","volume":"7","author":"T Francesco","year":"2024","unstructured":"Francesco T, de, Armstrong JJ, Hussein IM, Costa VP, Ahmed IIK, Mitomycin C. 0.2 mg\/ml versus Mitomycin C 0.4 mg\/ml during the Implantation of an ab externo polystyrene-isobutylene-styrene microshunt: a mega-analysis. Ophthalmol Glaucoma. 2024;7:454\u201365.","journal-title":"Ophthalmol Glaucoma"},{"key":"3843_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00055735-199804000-00002","volume":"9","author":"G Picht","year":"1998","unstructured":"Picht G, Grehn F. Classification of filtering blebs in trabeculectomy: biomicroscopy and functionality. Curr Opin Ophthalmol. 1998;9:2\u20138.","journal-title":"Curr Opin Ophthalmol"},{"key":"3843_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.exer.2015.03.021","volume":"142","author":"G Schlunck","year":"2016","unstructured":"Schlunck G, Meyer-ter-Vehn T, Klink T, Grehn F. Conjunctival fibrosis following filtering glaucoma surgery. Exp Eye Res. 2016;142:76\u201382.","journal-title":"Exp Eye Res"},{"key":"3843_CR23","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1167\/iovs.13-12274","volume":"54","author":"J Freedman","year":"2013","unstructured":"Freedman J, Iserovich P. Pro-inflammatory cytokines in glaucomatous aqueous and encysted Molteno implant blebs and their relationship to pressure. Invest Ophthalmol Vis Sci. 2013;54:4851\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3843_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5005\/jp-journals-10008-1206","volume":"10","author":"M Coote","year":"2016","unstructured":"Coote M. Blebs, barriers, and bagpipes: why is it so hard? J Curr glaucoma Pract. 2016;10:79\u201384.","journal-title":"J Curr glaucoma Pract"},{"key":"3843_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0134-8","volume":"15","author":"O Yamanaka","year":"2015","unstructured":"Yamanaka O, Kitano-Izutani A, Tomoyose K, Reinach PS. Pathobiology of wound healing after glaucoma filtration surgery. BMC Ophthalmol. 2015;15:157.","journal-title":"BMC Ophthalmol"},{"key":"3843_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.diff.2013.07.004","volume":"86","author":"PA Janmey","year":"2013","unstructured":"Janmey PA, Wells RG, Assoian RK, McCulloch CA. From tissue mechanics to transcription factors. Differ Res Biol Diversity. 2013;86:112\u201320.","journal-title":"Differ Res Biol Diversity"},{"key":"3843_CR27","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1111\/aos.14602","volume":"99","author":"Scheres","year":"2021","unstructured":"Scheres, Kujovic-Aleksov LMJ, Ramdas S, Crom WD, de RMPC, Roelofs LCG, et al. XEN\u00ae Gel Stent compared to PRESERFLO\u2122 MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmologica. 2021;99:e433\u2013e440.","journal-title":"Acta Ophthalmologica"},{"key":"3843_CR28","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s00417-023-06075-4","volume":"261","author":"M Jamke","year":"2023","unstructured":"Jamke M, Herber R, Haase MA, Jasper CS, Pillunat LE, Pillunat KR. PRESERFLO \u2122 MicroShunt versus trabeculectomy: 1-year results on efficacy and safety. Graefes Arch Clin Exp Ophthalmol. 2023;261:2901\u201315.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3843_CR29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s10792-019-01267-6","volume":"40","author":"K Iwasaki","year":"2020","unstructured":"Iwasaki K, Kakimoto H, Arimura S, Takamura Y, Inatani M. Prospective cohort study of risk factors for choroidal detachment after trabeculectomy. Int Ophthalmol. 2020;40:1077\u201383.","journal-title":"Int Ophthalmol"},{"key":"3843_CR30","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1007\/s10792-022-02342-1","volume":"42","author":"NY Ercalik","year":"2022","unstructured":"Ercalik NY, Tekcan H, Mangan MS, Ozcelik Kose A, Imamoglu S. Analysis of risk factors and ocular hypotony characteristics in choroidal detachment after penetrating glaucoma surgery. Int Ophthalmol. 2022;42:3431\u201340.","journal-title":"Int Ophthalmol"},{"key":"3843_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ajo.2005.02.013","volume":"140","author":"HD Jampel","year":"2005","unstructured":"Jampel HD, Musch DC, Gillespie BW, Lichter PR, Wright MM, Guire KE. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol. 2005;140:16\u201322.","journal-title":"Am J Ophthalmol"},{"key":"3843_CR32","first-page":"1417","volume":"7","author":"A Haga","year":"2013","unstructured":"Haga A, Inatani M, Shobayashi K, Kojima S, Inoue T, Tanihara H. Risk factors for choroidal detachment after trabeculectomy with mitomycin C. Clin Ophthalmol. 2013;7:1417\u201321.","journal-title":"Clin Ophthalmol"},{"key":"3843_CR33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ogla.2021.08.005","volume":"5","author":"AM Fea","year":"2022","unstructured":"Fea AM, Laffi GL, Martini E, Economou MA, Caselgrandi P, Sacchi M, et al. Effectiveness of MicroShunt in patients with primary open-angle and pseudoexfoliative glaucoma: a retrospective European multicenter study. Ophthalmol Glaucoma. 2022;5:210\u20138.","journal-title":"Ophthalmol Glaucoma"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03843-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03843-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03843-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:05:11Z","timestamp":1757171111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03843-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3843"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03843-w","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have received payments from the company Santen for travel costs and holding lectures in user group meetings organized by the company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}